The clinical importance of a cytokine network in the acute phase of sepsis

Scientific Reports

Volumn 8, Issue 1, 2018, Pages

  Matsumoto, Hisatake ^a   Ogura, Hiroshi ^a   Shimizu, Kentaro ^a   Ikeda, Mitsunori ^a   Hirose, Tomoya ^a   Matsuura, Hiroshi ^a   Kang, Sujin ^a   Takahashi, Kanae ^b   Tanaka, Toshio ^a   Shimazu, Takeshi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE;

AGED; BLOOD; CASE CONTROL STUDY; DISEASE EXACERBATION; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SEPSIS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOMARKERS; CASE-CONTROL STUDIES; CYTOKINES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; ROC CURVE; SEPSIS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

EID: 85053501591     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-018-32275-8     Document Type: Article

References (40)

1. Rhodes, A. et al. Surviving Sepsis Campaign. International Guidelines for Management of Sepsis and Septic Shock: 2016. Crit. Care Med. 45, 486–552 (2017)
2. Levi, M. & van der Poll, T. Coagulation and sepsis. Thromb. Res. 149, 38–44 (2017)
3. Amarasekara, D. S., Yu, J. & Rho, J. Bone loss triggered by the cytokine network in inflammatory autoimmune diseases. J. Immunol. Res. 2015, 832127 (2015)
4. Chen, S.-J. et al. Current status of the immunomodulation and immunomediated therapeutic strategies for multiple sclerosis. Clin. Dev. Immunol. 2012, 970789 (2012)
5. Barnes, P. J. The cytokine network in chronic obstructive pulmonary disease. Am. J. Respir. Cell Mol. Biol. 41, 631–8 (2009)
6. Schett, G., Elewaut, D., McInnes, I. B., Dayer, J.-M. & Neurath, M. F. How cytokine networks fuel inflammation: Toward a cytokine-based disease taxonomy. Nat. Med. 19, 822–4 (2013)
7. Pierrakos, C. & Vincent, J.-L. Sepsis biomarkers: a review. Crit. Care. 14, R15 (2010)
8. Terpstra, M. L., Aman, J., van Nieuw Amerongen, G. P. & Groeneveld, A. B. Plasma biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis. Crit. Care Med. 42, 691–700 (2014)
9. Sousa, A. et al. Measurement of cytokines and adhesion molecules in the first 72 hours after severe trauma: association with severity and outcome. Dis. Markers. 2015, 747036 (2015)
10. Bozza, F. A. et al. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit. Care 11, R49 (2007)
11. Mera, S. et al. Multiplex cytokine profiling in patients with sepsis. APMIS 119, 155–63 (2011)
12. Surbatovic, M. et al. Cytokine profile in severe Gram-positive and Gram-negative abdominal sepsis. Sci. Rep. 5, 11355 (2015)
13. Kraft, R. et al. Predictive Value of IL-8 for Sepsis and Severe Infections After Burn Injury: A Clinical Study. Shock 43, 222–7 (2015)
14. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med. 20, 864–74 (1992)
15. Singer, M. et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315, 801–10 (2016)
16. Knaus, W. A., Draper, E. A., Wagner, D. P. & Zimmerman, J. E. APACHE II: a severity of disease classification system. Crit. Care Med. 13, 818–29 (1985)
17. Janssens, U. et al. Value of SOFA (Sequential Organ Failure Assessment) score and total maximum SOFA score in 812 patients with acute cardiovascular disorders. Crit. Care 5, P225 (2001)
18. Gando, S. et al. A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit. Care Med. 34, 625–31 (2006)
19. Taylor, F. B. et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb. Haemost. 86, 1327–30 (2001)
20. Wada, H., Matsumoto, T. & Yamashita, Y. Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines. J. Intensive Care 2, 15 (2014)
21. Otto, G. P. et al. The late phase of sepsis is characterized by an increased microbiological burden and death rate. Crit. Care 15, R183 (2011)
22. Ferreira, F. L., Bota, D. P., Bross, A., Mélot, C. & Vincent, J. L. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 286, 1754–8 (2001)
23. Shannon, P. et al. Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks. Genome Res. 13, 2498–504 (2003)
24. Andaluz-Ojeda, D. et al. A combined score of pro- and anti-inflammatory interleukins improves mortality prediction in severe sepsis. Cytokine 57, 332–6 (2012)
25. Koyama, K. & Nunomiya, S. Single measurement of plasminogen activator inhibitor-1 in sepsis: Is it useful for evaluating the severity or prognosis of sepsis? J. Intensive Care 5, 4–5 (2017)
26. Oda, S. et al. Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis. Cytokine 29, 169–75 (2005)
27. Harrell, F. E. Overview of maximum likelihood estimation in regression modeling strategies: with applications to linear models, logistic and ordinal regression, and survival analysis. 179–213 (Springer, 2001)
28. van der Poll, T. & Opal, S. M. Host-pathogen interactions in sepsis. Lancet Infect. Dis. 8, 32–43 (2008)
29. Martin, T., Cardarelli, P. M., Parry, G. C., Felts, K. A. & Cobb, R. R. Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-kappa B and AP-1. Eur. J. Immunol. 27, 1091–7 (1997)
30. Schulte, W., Bernhagen, J. & Bucala, R. Cytokines in sepsis: potent immunoregulators and potential therapeutic targets–an updated view. Mediators Inflamm. 2013, 165974 (2013)
31. Waters, J. P., Pober, J. S. & Bradley, J. R. Tumour necrosis factor in infectious disease. J. Pathol. 230, 132–47 (2013)
32. Tanaka, T., Narazaki, M. & Kishimoto, T. Immunotherapeutic implications of IL-6 blockade for cytokine storm. Immunotherapy 8, 959–70 (2016)
33. Ince, C. et al. The endothelium in sepsis. Shock 45, 259–70 (2016)
34. Schraufstatter, I. U., Chung, J. & Burger, M. IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac signaling pathways. Am. J. Physiol. Lung Cell. Mol. Physiol. 280, L1094–103 (2001)
35. Werle, M., Schmal, U., Hanna, K. & Kreuzer, J. MCP-1 induces activation of MAP-kinases ERK, JNK and p38 MAPK in human endothelial cells. Cardiovasc. Res. 56, 284–92 (2002)
36. Iskander, K. N. et al. Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding. Physiol. Rev. 93, 1247–88 (2013)
37. Xiao, W. et al. A genomic storm in critically injured humans. J. Exp. Med. 208, 2581–90 (2011)
38. Østerud, B. Tissue factor expression in blood cells. Thromb. Res. 125, Supplement 1 S31–34 (2010)
39. Egorina, E. M., Sovershaev, M. A. & Hansen, J. B. The role of tissue factor in systemic inflammatory response syndrome. Blood Coagul. Fibrinolysis 22, 451–6 (2011)
40. Levi, M. & van der Poll, T. Endothelial injury in sepsis. Intensive Care Med. 39, 1839–42 (2013)